Industry Reports

Custom Research

About

Knowledge Center

Contact

Global Interventional Cardiology Devices Market Assessment, By Product Type [Stents, Catheters, Balloons, Sheaths, Valves, Accessories, and Others], By End-user [Hospitals, Ambulatory Surgical Centers, Cardiology Clinics], By Region, Opportunities and Forecast, 2017-2031F

Q: What are the regions covered in the final report for the global interventional cardiology devices market?

The regions covered in the final report for the global interventional cardiology devices market are North America, Europe, Asia-Pacific, South America, and Middle East and Africa.

Q: What are the major drivers influencing the growth of the global interventional cardiology devices market?

The major factors influencing the global interventional cardiology devices market growth are the growing prevalence of cardiovascular disorders leading to surgeries, technological advancements in surgical products, and regulatory emphasis on interventional cardiology devices.

Q: Who are the key players operating in the global interventional cardiology devices market?

The key players operating in the global interventional cardiology devices market are Abbott Laboratories, Terumo Corporation, Teleflex Incorporated, B. Braun SE, Biosensors International Group, ACIST Medical Systems, Cook Medical, Merit Medical Systems, Boston Scientific Corporation, and Medtronic plc.

Q: What is the market size and growth rate of the global interventional cardiology devices market?

The global interventional cardiology devices market size was valued at USD 16.22 billion in 2023, which is expected to grow to USD 30.86 billion in 2031, with a CAGR of 8.37% for the forecast period between 2024 and 2031.

Global interventional cardiology devices market is expected to experience rapid growth due to the growing prevalence of cardiovascular disorders, technological advancements in cardiology devices, and regulatory emphasis.

Home>Industry Reports>Global Interventional Cardiology Devices Market Assessment, Opportunities and Forecast, 2017-2031F

Global interventional cardiology devices market is projected to witness a CAGR of 8.37% during the forecast period 2024-2031, growing from USD 16.22 billion in 2023 to USD 30.86 billion in 2031. The interventional cardiology devices market is thriving due to factors like a growing prevalence of cardiovascular disorders, technological advancements in cardiology devices, an increasing number of regulatory approvals, a growing geriatric population, rising awareness about cardiac conditions and treatment options, and increasing healthcare expenditure. Government initiatives and contributions from non-profit medical organizations to reduce the cardiac disease burden and strengthen the healthcare infrastructure are some other factors positively impacting the interventional cardiology devices market growth.

However, the dominance of first-line alternative treatment options pushes back the demand for interventional cardiology devices. The high cost of surgical procedures and instruments used for cardiac surgery makes it the terminal choice for middle and lower-class patients. Alongside, risks associated with cardiac surgeries and interventional devices hinder the growth of this market.

In November 2023, Argon Medical Devices, a trusted provider of device solutions for interventional radiology, vascular surgery, interventional cardiology, and oncology, introduced the Kodiak Dual Port Coaxial Introducer Kit. This innovative kit enables precise and streamlined introduction of diagnostic and therapeutic devices into the vasculature, ensuring optimum results for patients.

Technological Advancements in Cardiology Devices

Technological advancements in interventional cardiology devices have been significant in recent years. These advancements include the use of robotic technologies, miniature surgical robots controlled by surgeons, navigational sensors for precision, and wireless technologies with biosensors. Additionally, advancements in robotic percutaneous coronary intervention (PCI) technology, including improvements in wire manipulation, guide catheter control, and IVUS imaging, have been observed. Furthermore, wireless technologies and biosensors hold promise for interventional cardiology, as they can be used for various applications such as monitoring and diagnosis. These advancements are enhancing the precision, safety, and effectiveness of interventional cardiology procedures, ultimately benefiting interventional cardiology devices. Key players are designing products with enhanced technologies to cater to the market needs.

In September 2023, Canon Medical launched the Alphenix Sky 12 HD interventional system with the new high-definition (Hi-Def) detector. The Alphenix Sky 12 HD features a 12”×12” Hi-Def detector to improve visualization for interventional procedures, including pediatric cases, in cardiology, neurology, oncology, and radiology.

Download Free Sample Report

Growing Prevalence of Cardiovascular Diseases

Cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. The prevalence of cardiovascular diseases is expected to increase substantially due to factors such as population growth and aging. The rise in cardiovascular disease cases is attributed to a lack of translation of existing knowledge about cardiovascular diseases and risk factors into practice. The burden of cardiovascular diseases is particularly heavy on low- and middle-income countries, where they contribute to poverty and place a significant economic strain. Unhealthy diet, physical inactivity, tobacco use, and alcohol consumption are among the most important behavioral risk factors for cardiovascular diseases. The demand for interventional cardiology devices is expected to increase significantly with the growing prevalence of cardiovascular diseases.

For instance, according to the World Heart Report 2023 published by the World Heart Federation, cardiovascular diseases have been the leading cause of death worldwide for many years. In 2021, more than 20 million people died from a cardiovascular condition, which accounted for about one-third of all global deaths. This figure is significantly higher than the 12.1 million cardiovascular disease deaths recorded in 1990. Ischemic heart disease is now the leading cause of premature death in 146 countries for men and 98 countries for women.

Dominance of Stents Segment

The stents segment is anticipated to be the leading segment in the interventional cardiology devices market. Stents are commonly used in interventional cardiology to treat coronary artery disease. They are expandable tubular metallic devices introduced into clogged coronary arteries, a procedure known as percutaneous coronary intervention (PCI) or coronary stenting. The most widely used stents are drug-eluting stents (DES), which have significantly reduced the incidence of restenosis in native stable coronary arteries. Stents have been shown to reduce angina and improve survival in patients with coronary artery disease. Innovative stent products from market players have significantly developed the market.

In October 2023, Medinol announced the United States Food and Drug Administration (FDA) approval for its EluNIR-PERL drug-eluting stent (DES), which is meant for the treatment of coronary artery disease. EluNIR-PERL has four radiopaque markers, two at each end, and a hybrid polymer-metal radiopaque catheter tip. These unique features allow excellent visualization during PCI procedures, whether navigating through complex anatomies or placing the stent precisely.

Ambulatory Surgical Centers to be the Fastest Growing End-user Segment

Cardiology procedures are increasingly being performed in ambulatory surgery centers (ASCs) due to various factors such as improved patient experiences, strong reimbursement rates, and cost savings. These procedures include the placement of pacemakers, loop recorders, AICD, diagnostic and interventional coronary procedures, peripheral vascular interventions, right and left heart catheterizations, coronary interventions, and defibrillator and pacemaker implants. The Centers for Medicare and Medicaid Services (CMS) support this shift to ASCs by adding cardiology procedures to the ASC-covered procedure list. This has led to a faster growth rate for ambulatory surgical centers. For instance, as per an article published by HMP Global in July 2023, around 2% of major cardiovascular procedures are being performed in ambulatory surgical centers and the traction is steadily rising.

North America to be the Dominating Region

North America is anticipated to be the leading region in interventional cardiology devices. The region has a high prevalence of cardiovascular diseases, leading to a significant demand for cardiology devices. Additionally, North America has a high adoption rate of minimally invasive procedures and a strong presence of top manufacturers in the interventional cardiology device market. The rising healthcare expenditure and high disposable incomes in North America also contribute to the dominance of the region in the interventional cardiology devices market. Alongside, prominent players in the interventional cardiology device market, such as Medtronic, Boston Scientific Corporation, and Abbott, have a strong presence in North America, further contributing to its dominance.

As per the American Heart Association, by 2035, almost 45% of the United States population is expected to experience heart disease due to unhealthy factors such as high obesity rates, smoking, and poor lifestyle choices. These factors may increase the risk of heart attacks and other related health issues.

Future Market Scenario (2024 – 2031F)

In recent years, notable regulatory emphasis has been helpful for novel marketed products. Several reforms have been made to speed up the approval process of interventional cardiology devices. The FDA has been granting several regulatory approvals for interventional cardiology devices. The classification of interventional cardiovascular implant simulation software devices has been updated to class II (special controls). Most class III devices require FDA approval of a PMA before they can be legally marketed. The classification of cardiovascular devices intended for human use that are in commercial distribution is outlined in 21 CFR Part 870. The number of cardiac device approvals for children seems to be growing, with most approvals being granted through the humanitarian device exemption (HDE) pathway.

In November 2023, Medtronic plc received approval from the United States Food and Drug Administration (FDA) for its Symplicity Spyral renal denervation (RDN) system, which is also known as the Symplicity blood pressure procedure. This system has been approved for use in treating hypertension. As a result of the approval, Medtronic will start the commercialization of the product right away. The device is mainly meant to reduce hypertension through relaxing nerves connected to the kidneys and reducing its activity.

Report Scope

“Interventional Cardiology Devices Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global interventional cardiology devices market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031F. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.

Report Attribute	Details
Base Year of the Analysis	2023
Historical Period	2017-2022
Forecast Period	2024-2031F
Projected Growth Rate	CAGR of 8.37% between 2024 and 2031F
Revenue Forecast in 2031	USD 30.86 billion
Segments Covered	Product Type, End-user
Regions Covered	North America, Europe, South America, Asia-Pacific, Middle East and Africa
Key Companies Profile	Abbott Laboratories, Terumo Corporation, Teleflex Incorporated, B. Braun SE, Biosensors International Group, ACIST Medical Systems, Cook Medical, Merit Medical Systems, Boston Scientific Corporation, Medtronic plc
Customization Scope	15% free report customization with purchase
Pricing and Purchase Options	Avail the customized purchase options to fulfill your precise research needs
Delivery Format	PDF and Excel through email (subject to the license purchased)

In this report, the global interventional cardiology devices market has been segmented into the following categories:

· By Product Type

o Stents

§ Bare-Metal Stents

§ Drug -Eluting Stents

§ Bio Absorbable Stent

§ Others

o Catheters

§ Angiography Catheters

§ Atherectomy Catheters

§ Thrombectomy Catheters

§ Ablation Catheters

§ IVUS Catheters

§ Others

o Balloons

§ PTCA Balloons

§ Valvuloplasty Balloons

§ Others

o Sheaths

o Valves

o Accessories and others

· By End-user

o Hospitals

o Ambulatory Surgical Centers

o Cardiology Clinics

o Others

· By Region

o North America

o Europe

o Asia-Pacific

o South America

o Middle East and Africa

Key Players Landscape and Outlook

The key players in the interventional cardiology devices market include Abbott Laboratories, Terumo Corporation, Teleflex Incorporated, and B. Braun SE, among others. Many companies are working on developing new products and expanding their business through collaborations, partnerships, mergers, and strategic alliances. The market value of these players is driven by the successful implementation of these strategies. Additionally, regulatory approvals for new products and services also contribute to the growth of both the players and the market.

In October 2023, Haemonetics offered USD 253 million for sensor equipped TAVR guidewire maker OpSens. The deal is expected to close in January 2024. Haemonetics is a Boston-based medical device maker, while OpSens is a Canadian developer of optical sensor-equipped devices for both medical and industrial uses.

Key Players Operating in the Global Interventional Cardiology Devices Market are:

· Abbott Laboratories

· Terumo Corporation

· Teleflex Incorporated

· B. Braun SE

· Biosensors International Group

· ACIST Medical Systems

· Cook Medical

· Merit Medical Systems

· Boston Scientific Corporation

· Medtronic plc

Markets and Data’s reports answer the following questions:

· What is the current and future market size of the product/service in question globally or specific to different countries?

· How are the markets divided into different product/service segments and the market size and growth of each segment?

· What is the market potential of different product segments and their investment case?

· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?

· What is the business environment and regulatory landscape specific to the product/service?

If you can't find what you're searching for or have any custom requirements for the global interventional cardiology devices market, you may approach our team at info@marketsandata.com

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Interventional Cardiology Devices Market Outlook, 2017-2031F

4.1. Market Size & Forecast

4.1.1. By Value

4.1.2. By Volume

4.2. By Product Type

4.2.1.Stents

4.2.1.1. Bare-Metal Stents

4.2.1.2. Drug-Eluting Stents

4.2.1.3. Bio Absorbable Stent

4.2.1.4. Others

4.2.2.Catheters

4.2.2.1. Angiography Catheters

4.2.2.2. Atherectomy Catheters

4.2.2.3. Thrombectomy Catheters

4.2.2.4. Ablation Catheters

4.2.2.5. IVUS Catheters

4.2.2.6. Others

4.2.3.Balloons

4.2.3.1. PTCA Balloons

4.2.3.2. Valvuloplasty Balloons

4.2.3.3. Others

4.2.4.Sheaths

4.2.5.Valves

4.2.6.Accessories and others

4.3. By End-user

4.3.1.Hospitals

4.3.2.Ambulatory Surgical Centers

4.3.3.Cardiology Clinics

4.4. By Region

4.4.1. North America

4.4.2. Europe

4.4.3. Asia-Pacific

4.4.4. South America

4.4.5. Middle East and Africa

4.5. By Company Market Share (%), 2023

5. Global Interventional Cardiology Devices Market Outlook, By Region, 2017-2031F

5.1. North America*

5.1.1.Market Size & Forecast

5.1.1.1. By Value

5.1.1.2. By Volume

5.1.2.By Product Type

5.1.2.1. Stents

5.1.2.1.1. Bare-Metal Stents

5.1.2.1.2. Drug-Eluting Stents

5.1.2.1.3. Bio Absorbable Stent

5.1.2.1.4. Others

5.1.2.2. Catheters

5.1.2.2.1. Angiography Catheters

5.1.2.2.2. Atherectomy Catheters

5.1.2.2.3. Thrombectomy Catheters

5.1.2.2.4. Ablation Catheters

5.1.2.2.5. IVUS Catheters

5.1.2.2.6. Others

5.1.2.3. Balloons

5.1.2.3.1. PTCA Balloons

5.1.2.3.2. Valvuloplasty Balloons

5.1.2.3.3. Others

5.1.2.4. Sheaths

5.1.2.5. Valves

5.1.2.6. Accessories and others

5.1.3.By End-user

5.1.3.1. Hospitals

5.1.3.2. Ambulatory Surgical Centers

5.1.3.3. Cardiology Clinics

5.1.4.United States*

5.1.4.1. Market Size & Forecast

5.1.4.1.1. By Value

5.1.4.1.2. By Volume

5.1.4.2. By Product Type

5.1.4.2.1. Stents

5.1.4.2.1.1. Bare-Metal Stents

5.1.4.2.1.2. Drug-Eluting Stents

5.1.4.2.1.3. Bio Absorbable Stent

5.1.4.2.1.4. Others

5.1.4.2.2. Catheters

5.1.4.2.2.1. Angiography Catheters

5.1.4.2.2.2. Atherectomy Catheters

5.1.4.2.2.3. Thrombectomy Catheters

5.1.4.2.2.4. Ablation Catheters

5.1.4.2.2.5. IVUS Catheters

5.1.4.2.2.6. Others

5.1.4.2.3. Balloons

5.1.4.2.3.1. PTCA Balloons

5.1.4.2.3.2. Valvuloplasty Balloons

5.1.4.2.3.3. Others

5.1.4.2.4. Sheaths

5.1.4.2.5. Valves

5.1.4.2.6. Accessories and others

5.1.4.3. By End-user

5.1.4.3.1. Hospitals

5.1.4.3.2. Ambulatory Surgical Centers

5.1.4.3.3. Cardiology Clinics

5.1.5.Canada

5.1.6.Mexico

*All segments will be provided for all regions and countries covered

5.2. Europe

5.2.1.Germany

5.2.2.France

5.2.3.Italy

5.2.4.United Kingdom

5.2.5.Russia

5.2.6.Netherlands

5.2.7.Spain

5.2.8.Turkey

5.2.9.Poland

5.3. Asia-Pacific

5.3.1.India

5.3.2.China

5.3.3.Japan

5.3.4.Australia

5.3.5.Vietnam

5.3.6.South Korea

5.3.7.Indonesia

5.3.8.Philippines

5.4. South America

5.4.1.Brazil

5.4.2.Argentina

5.5. Middle East & Africa

5.5.1.Saudi Arabia

5.5.2.UAE

5.5.3.South Africa

6. Market Mapping, 2023

6.1. By Product Type

6.2. By End-user

6.3. By Region

7. Macro Environment and Industry Structure

7.1. Demand Supply Analysis

7.2. Import Export Analysis

7.3. Value Chain Analysis

7.4. PESTEL Analysis

7.4.1. Political Factors

7.4.2. Economic System

7.4.3. Social Implications

7.4.4. Technological Advancements

7.4.5. Environmental Impacts

7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)

7.5. Porter’s Five Forces Analysis

7.5.1.Supplier Power

7.5.2.Buyer Power

7.5.3.Substitution Threat

7.5.4.Threat from New Entrant

7.5.5.Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers

8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Clinical Trials

9.2. Patent Landscape

9.3. Regulatory Approvals

9.4. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders

10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)

10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)

10.4. SWOT Analysis (For Five Market Players)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Abbott Laboratories

13.1.1. Company Details

13.1.2. Key Management Personnel

13.1.3. Products & Services

13.1.4. Financials (As reported)

13.1.5. Key Market Focus & Geographical Presence

13.1.6. Recent Developments

13.2. Terumo Corporation

13.3. Teleflex Incorporated

13.4. B. Braun SE

13.5. Biosensors International Group

13.6. ACIST Medical Systems

13.7. Cook Medical

13.8. Merit Medical Systems

13.9. Boston Scientific Corporation

13.10. Medtronic plc

*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Figures:

Figure 1. Global Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 2. Global Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 3. Global Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 4. Global Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 5. Global Interventional Cardiology Devices Market Share (%), By Region, 2017-2031F

Figure 6. North America Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 7. North America Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 8. North America Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 9. North America Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 10. North America Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F

Figure 11. United States Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 12. United States Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 13. United States Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 14. United States Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 15. Canada Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 16. Canada Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 17. Canada Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 18. Canada Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 19. Mexico Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 20. Mexico Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 21. Mexico Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 22. Mexico Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 23. Europe Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 24. Europe Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 25. Europe Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 26. Europe Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 27. Europe Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F

Figure 28. Germany Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 29. Germany Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 30. Germany Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 31. Germany Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 32. France Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 33. France Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 34. France Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 35. France Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 36. Italy Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 37. Italy Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 38. Italy Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 39. Italy Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 40. United Kingdom Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 41. United Kingdom Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 42. United Kingdom Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 43. United Kingdom Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 44. Russia Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 45. Russia Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 46. Russia Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 47. Russia Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 48. Netherlands Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 49. Netherlands Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 50. Netherlands Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 51. Netherlands Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 52. Spain Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 53. Spain Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 54. Spain Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 55. Spain Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 56. Turkey Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 57. Turkey Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 58. Turkey Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 59. Turkey Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 60. Poland Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 61. Poland Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 62. Poland Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 63. Poland Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 64. South America Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 65. South America Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 66. South America Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 67. South America Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 68. South America Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F

Figure 69. Brazil Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 70. Brazil Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 71. Brazil Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 72. Brazil Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 73. Argentina Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 74. Argentina Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 75. Argentina Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 76. Argentina Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 77. Asia-Pacific Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 78. Asia-Pacific Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 79. Asia-Pacific Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 80. Asia-Pacific Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 81. Asia-Pacific Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F

Figure 82. India Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 83. India Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 84. India Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 85. India Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 86. China Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 87. China Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 88. China Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 89. China Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 90. Japan Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 91. Japan Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 92. Japan Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 93. Japan Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 94. Australia Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 95. Australia Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 96. Australia Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 97. Australia Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 98. Vietnam Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 99. Vietnam Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 100. Vietnam Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 101. Vietnam Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 102. South Korea Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 103. South Korea Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 104. South Korea Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 105. South Korea Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 106. Indonesia Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 107. Indonesia Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 108. Indonesia Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 109. Indonesia Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 110. Philippines Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 111. Philippines Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 112. Philippines Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 113. Philippines Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 114. Middle East & Africa Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 115. Middle East & Africa Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 116. Middle East & Africa Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 117. Middle East & Africa Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 118. Middle East & Africa Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F

Figure 119. Saudi Arabia Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 120. Saudi Arabia Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 121. Saudi Arabia Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 122. Saudi Arabia Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 123. UAE Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 124. UAE Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 125. UAE Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 126. UAE Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 127. South Africa Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F

Figure 128. South Africa Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F

Figure 129. South Africa Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F

Figure 130. South Africa Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F

Figure 131. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023

Figure 132. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023

Figure 133. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

List of Tables

Table 1. Pricing Analysis of Products from Key Players

Table 2. Competition Matrix of Top 5 Market Leaders

Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)

Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

Frequently Asked Questions

What are the regions covered in the final report for the global interventional cardiology devices market?

What are the major drivers influencing the growth of the global interventional cardiology devices market?

Who are the key players operating in the global interventional cardiology devices market?

What is the market size and growth rate of the global interventional cardiology devices market?

See Related Reports

View ALL

Global Bone Densitometers Market Assessment, Opportunities and Forecast, 2017-2031F

There is an increased demand for dual-energy x-ray absorptiometry (DXA) in the global bone densitometers market. Also, increasing prevalence of osteoporosis, growing geriatric population, technological advancements, and collaborative research and new....Read More

Published on

May 2024

4,500

Global Medical Terminology Software Market Assessment, Opportunities and Forecast, 2017-2031F

Global medical terminology software market is expected to witness significant growth over the forecast period owing to an increase in measures for reducing clinical errors and rising investments towards the development of technologically advanced sol....Read More

Published on

May 2024

4,500

Global Legionella Testing Market Assessment, Opportunities and Forecast, 2017-2031F

Global legionella testing market will witness significant growth owing to the rapid expansion of the healthcare sector, increasing awareness about the importance of regular legionella testing, and rising prevalence of legionella related illnesses.....Read More

Published on

May 2024

4,500

Global Endoluminal Suturing Devices Market Assessment, Opportunities and Forecast, 2017-2031F

Global endoluminal suturing devices market is expected to witness significant growth over the forecast period owing to rise in the number of cases of gastrointestinal cancer and increasing preference for non-invasive procedures.....Read More

Published on

May 2024

4,500

Purchase Options

USD ($)